Live Breaking News & Updates on Asia Pacific Rainbow

Stay updated with breaking news from Asia pacific rainbow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC

GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC –2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific – – Since 2018, The Gilead Asia Pacific R. ....

United States , Hong Kong , Foster City , Republic Of , South Korea , Janet Dorling , Fletcher Chiu , Asia Pacific , Asia Pacific Rainbow , Gilead Sciences Inc , Intercontinental Region Global Patient Solutions , Right Advocacy Association Taiwan , World Health Organization , Gilead Sciences , United Nations Program , Education And Services , Shanghai Qingai Health Promotion Center , Improve Equity Across Asia Pacific , Based Projects In The Region , Counselled For , Pacific Rainbow Grant , Chinese Mainland , Shanghai Qing Ai Health Promotion Center , Impact Report , Joint United Nations Program , Gilead Asia Pacific Rainbow Grant ,

GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023

-Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with MoreThan US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date - - Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innovative Projects Centered on Theme 'Reducing Stigma & Improving Equity' - SINGAPORE, May 1, 2023 /PRNewswire/ Gilead Sciences, Inc. today announced the launch of its 2023 Asia Pacific Rainbow Grant, marking the fifth anniversary milestone of a regional program which supports community projects to address HIV-related needs in Asia Pacific. Non-profit organizations are invited to submit their applications for 2023 funding online through the Gilead Grant portalstarting today. The submission deadline ends on 28 July 2023, 11:59pm GMT+8. In Asia Pacific, there are still about six million people living with HIV in the region[1] who face social and cultural stigma and punitive laws that preve ....

Foster City , United States , Alex Kalomparis , Asia Pacific Rainbow , Asia Pacific , Prnewswire Gilead Sciences Inc , Gilead Sciences , Public Affairs , Grant Program , Gilead Sciences Inc , Gilead Sciences Celebrates , Fifth Anniversary Milestone , Asia Pacific Rainbow Grant , More Than , Asia Pacific Region , Focused Community Based Organizations , Innovative Projects Centered , Reducing Stigma , Improving Equity , Pacific Rainbow Grant , Gilead Grant , Gilead Asia Pacific Rainbow Grant , Senior Vice President , Ilead Sciences Celebrates The Fifth Anniversary Milestone Of Asia Pacific Rainbow Grant , Ith Morethan Us 4 5 Million Awarded To Organizations Across The Asia Pacific Region Date Grant Program In 2023 Invites Hiv Focused Community Based Apply For Funding Innovative Projects Centered On Theme 39 Reducing Stigma Amp Improving Equity Singapore , May 1 ,

TELEHEALTH USAGE IN ASIA PACIFIC FOR PEOPLE LIVING WITH HIV INCREASING, BUT DATA PRIVACY AND LACK OF PERSONAL CONTACT STILL SEEN AS A BARRIER TO WIDER USE

- Half of the people living with HIV (PLHIV) and individuals at-risk (IARs) surveyed in the region increased their usage of telehealth services over the past year; this is driven by the availability of new telehealth services during pandemic - Top factor impacting usage of telehealth services for PLHIV is data privacy (43%), while lack of personal contact is the primary concern for IARs (47%) - Around 1 in 3 respondents chose telehealth services provided by healthcare providers (HCPs) as the most trustworthy source for HIV prevention and care information SINGAPORE, Nov. 28, 2022 /PRNewswire/ As the COVID-19 pandemic continues to disrupt the access and delivery of essential care worldwide, Gilead Sciences today announced findings from a survey conducted to examine changes in the motivations and use of telehealth services for people living with HIV (PLHIV) and individuals at-risk (IARs) in the Asia Pacific. The regional survey results were based on responses from 1,531 respondents, co ....

Hong Kong , Republic Of , United States , South Korea , Foster City , Sumita Banerjee , Caroline Choi , Cerner Enviza , Asia Pacific , Asia Pacific Rainbow , Asia Pacific Hong Kong , Affairs Asia , Gilead Sciences , Kantar Health , Clinic Pte Ltd , Senior Director , Medical Affairs Asia , Community Based Organizations , Executive Director , Funders Concerned About , Asia Pacific Rainbow Grant , Alf Of The People Living With Hiv Plhiv And Individuals At Risk Iars Surveyed In Region Increased Their Usage Telehealth Services Over Past Year This Is Driven By Availability New During Pandemic Top Factor Impacting For Data Privacy 43 , Hile Lack Of Personal Contact Is The Primary Concern For Iars 47 Around 1 In 3 Respondents Chose Telehealth Services Provided By Healthcare Providers Hcps As Most Trustworthy Source Hiv Prevention And Care Information Singapore , Ov 28 , 022 Prnewswire As The Covid 19 Pandemic Continues To Disrupt Access And Delivery Of Essential Care Worldwide , Ilead Sciences Today Announced Findings Froma Survey Conducted To Examine Changes In The Motivations And Use Of Telehealth Services For People Living With Hiv Plhiv Individuals At Risk Iars Asia Pacific Regional Results Were Based On Responses From 1 ,

GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS

In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally Gilead also ranks first among peers in Asia by patient groups in this region HONG KONG, Sept. 15, 2022 /PRNewswire/ Gilead Sciences, Inc. ranks first among peers for overall corporate reputation, according to 300 Asian patient groups and 111 hepatitis patient groups in the 2021 PatientView Corporate Reputation of Pharma survey. This recognition is testament to Gilead's strong focus on patient centricity and deep commitment to working with patient groups to enhance the quality of care for communities across the world. "This is a remarkable achievement for Gilead and it is heartening to know that patient groups rate us highly in all areas - seeing us as the partner of choice," said Dustin Haines, Vice President & General Manager, Asia 5, Gilead Sciences. "We put patients at the heart of everything we do, and ....

United States , Foster City , Asia Pacific Rainbow , Dustin Haines , Gilead Sciences , Gilead Sciences Inc , View Corporate Reputation , Vice President , General Manager , Asia Pacific Rainbow Grant , N The Recently Published Patientview Report , Ilead Is Ranked Number One In All Corporate Reputation Indicators By Hepatitis Patient Groups Globally Gilead Also Ranks First Among Peers Asia This Region Hong Kong , Sept 15 , 022 Prnewswire Gilead Sciences , Nc Ranks First Among Peers For Overall Corporate Reputation , Ccording To 300 Asian Patient Groups And 111 Hepatitis In The 2021 Patientview Corporate Reputation Of Pharma Survey This Recognition Is Testament Gilead 39s Strong Focus On Centricity Deep Commitment Working With Enhance Quality Care For Communities Across World Quot Isa Remarkable Achievement It Heartening Know That Rate Us Highly All Areas Seeing As Partner Choice , Uot Said Dustin Haines , Ice President Amp General Manager , Asia 5 , Ilead Sciences Quot We Put Patients At The Heart Of Everything Do , Nd This Is What Drives Our Deep Engagement And Collaboration With Diverse Patient Community Based Organizations Across Asia All Of Whom Are Dedicated To Supporting People Living Hiv Viral Hepatitis Focus On Centricity Key The Delivery High Quality Care , Hich We Strongly Believe Unlocks Better Health Outcomes For All Quot Since 2010 , Atientview Has Been Collecting Datafrom Respondent Patient Groups Globally On The Reputational Status Of Pharmaceutical Industry And Individual Companies Latest Survey Was Conducted Between November 2021 February 2022 For Third Year Ina Row , Ilead Placed First In The Survey Conducted With 111 Patient Groups Specializing Either Hepatitis Or Liver Conditions , Hich Had Collectively Been In Communication With 1 8 Million Patients Gilead Topped All Ten Corporate Reputation Indicators , Emonstrating Its Unparalleled Strengths In Educating ,